Friday, July 10, 2026

pharma · CACNA1A Disorders · Niemann-Pick disease type C

IntraBio

IntraBio drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Austin, USA HQ
44 Employees
EMA registrant Type
Company details
Status
Public
HQ
Austin, USA
Employees
44
Programs
3
Drugs
3
Patents
0
Intelligence · Drug Pipeline

IntraBio pipeline

Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

IntraBio drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

3 compounds
  1. Development asset linked to IntraBio in public FDA and regional records.

  2. Development asset linked to IntraBio in public FDA and regional records.

  3. Development asset linked to IntraBio in public FDA and regional records.